SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-24-000027
Filing Date
2024-03-08
Accepted
2024-03-08 16:10:15
Documents
16
Period of Report
2024-03-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K optn-20240308.htm   iXBRL 8-K 42697
2 EX-10.1 secondamendmenttonotepurch.htm EX-10.1 55304
6 GRAPHIC optn-20240308_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-24-000027.txt   257144

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20240308.xsd EX-101.SCH 1904
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20240308_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20240308_pre.xml EX-101.PRE 13048
17 EXTRACTED XBRL INSTANCE DOCUMENT optn-20240308_htm.xml XML 2528
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 24734412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)